Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 93

1.

Clozapine treatment of borderline patients: a preliminary study.

Frankenburg FR, Zanarini MC.

Compr Psychiatry. 1993 Nov-Dec;34(6):402-5.

PMID:
8131384
[PubMed - indexed for MEDLINE]
2.

Low-dose clozapine in acute and continuation treatment of severe borderline personality disorder.

Benedetti F, Sforzini L, Colombo C, Maffei C, Smeraldi E.

J Clin Psychiatry. 1998 Mar;59(3):103-7.

PMID:
9541151
[PubMed - indexed for MEDLINE]
3.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
[PubMed - indexed for MEDLINE]
4.

Efficacy and tolerability of quetiapine in the treatment of borderline personality disorder: A pilot study.

Bellino S, Paradiso E, Bogetto F.

J Clin Psychiatry. 2006 Jul;67(7):1042-6.

PMID:
16889446
[PubMed - indexed for MEDLINE]
5.

A preliminary double-blind, placebo-controlled trial of divalproex sodium in borderline personality disorder.

Hollander E, Allen A, Lopez RP, Bienstock CA, Grossman R, Siever LJ, Merkatz L, Stein DJ.

J Clin Psychiatry. 2001 Mar;62(3):199-203.

PMID:
11305707
[PubMed - indexed for MEDLINE]
6.

Clozapine in treatment-resistant patients with schizophrenia, schizoaffective disorder, or psychotic bipolar disorder: a naturalistic 48-month follow-up study.

Ciapparelli A, Dell'Osso L, Bandettini di Poggio A, Carmassi C, Cecconi D, Fenzi M, Chiavacci MC, Bottai M, Ramacciotti CE, Cassano GB.

J Clin Psychiatry. 2003 Apr;64(4):451-8.

PMID:
12716249
[PubMed - indexed for MEDLINE]
7.

Clozapine reduces severe self-mutilation and aggression in psychotic patients with borderline personality disorder.

Chengappa KN, Ebeling T, Kang JS, Levine J, Parepally H.

J Clin Psychiatry. 1999 Jul;60(7):477-84.

PMID:
10453803
[PubMed - indexed for MEDLINE]
8.

A double-blind comparative study of clozapine and risperidone in the management of severe chronic schizophrenia.

Azorin JM, Spiegel R, Remington G, Vanelle JM, Péré JJ, Giguere M, Bourdeix I.

Am J Psychiatry. 2001 Aug;158(8):1305-13.

PMID:
11481167
[PubMed - indexed for MEDLINE]
9.

Open-label study of atypical neuroleptic quetiapine for treatment of borderline personality disorder: impulsivity as main target.

Villeneuve E, Lemelin S.

J Clin Psychiatry. 2005 Oct;66(10):1298-303.

PMID:
16259544
[PubMed - indexed for MEDLINE]
10.

Clozapine and haloperidol in moderately refractory schizophrenia: a 6-month randomized and double-blind comparison.

Kane JM, Marder SR, Schooler NR, Wirshing WC, Umbricht D, Baker RW, Wirshing DA, Safferman A, Ganguli R, McMeniman M, Borenstein M.

Arch Gen Psychiatry. 2001 Oct;58(10):965-72.

PMID:
11576036
[PubMed - indexed for MEDLINE]
11.

[Clinical effects of clozapine: effect on negative symptoms].

Llorca PM, Lançon C, Auquier P, Bougerol T.

Encephale. 1996 Jul-Aug;22(4):287-92. French.

PMID:
9035984
[PubMed - indexed for MEDLINE]
12.

Clinical predictors of response to clozapine treatment in ambulatory patients with schizophrenia.

Umbricht DS, Wirshing WC, Wirshing DA, McMeniman M, Schooler NR, Marder SR, Kane JM.

J Clin Psychiatry. 2002 May;63(5):420-4.

PMID:
12019667
[PubMed - indexed for MEDLINE]
13.
14.

Olanzapine in refractory schizophrenia after failure of typical or atypical antipsychotic treatment: an open-label switch study.

Lindenmayer JP, Czobor P, Volavka J, Lieberman JA, Citrome L, Sheitman B, Chakos M, McEvoy JP.

J Clin Psychiatry. 2002 Oct;63(10):931-5.

PMID:
12416603
[PubMed - indexed for MEDLINE]
15.

Risperidone versus clozapine in treatment-resistant chronic schizophrenia: a randomized double-blind study. The Risperidone Study Group.

Bondolfi G, Dufour H, Patris M, May JP, Billeter U, Eap CB, Baumann P.

Am J Psychiatry. 1998 Apr;155(4):499-504.

PMID:
9545995
[PubMed - indexed for MEDLINE]
16.

Olanzapine for the treatment of borderline personality disorder: variable dose 12-week randomised double-blind placebo-controlled study.

Schulz SC, Zanarini MC, Bateman A, Bohus M, Detke HC, Trzaskoma Q, Tanaka Y, Lin D, Deberdt W, Corya S.

Br J Psychiatry. 2008 Dec;193(6):485-92. doi: 10.1192/bjp.bp.107.037903.

PMID:
19043153
[PubMed - indexed for MEDLINE]
Free Article
17.

Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.

Lewis SW, Davies L, Jones PB, Barnes TR, Murray RM, Kerwin R, Taylor D, Hayhurst KP, Markwick A, Lloyd H, Dunn G.

Health Technol Assess. 2006 May;10(17):iii-iv, ix-xi, 1-165.

PMID:
16707074
[PubMed - indexed for MEDLINE]
Free Article
18.

Emerging evidence for the use of atypical antipsychotics in borderline personality disorder.

Grootens KP, Verkes RJ.

Pharmacopsychiatry. 2005 Jan;38(1):20-3. Review.

PMID:
15706462
[PubMed - indexed for MEDLINE]
19.

Olanzapine safety and efficacy in patients with borderline personality disorder and comorbid dysthymia.

Schulz SC, Camlin KL, Berry SA, Jesberger JA.

Biol Psychiatry. 1999 Nov 15;46(10):1429-35.

PMID:
10578457
[PubMed - indexed for MEDLINE]
20.

The effects of clozapine on symptom clusters in treatment-refractory patients.

Abraham G, Nair C, Tracy JI, Simpson GM, Josiassen RC.

J Clin Psychopharmacol. 1997 Feb;17(1):49-53.

PMID:
9004057
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk